Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications
Pancreatic cancer (PC) is the fourth leading cause of cancer-related mortality with limited diagnostic and therapeutic options. Although immunotherapy has shown promise in the treatment of several cancers, its role in pancreatic cancer is rather limited. Several studies have focused on determining t...
Main Authors: | Suneetha Amara, Li V. Yang, Venkataswarup Tiriveedhi, Mahvish Muzaffar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/12/1900 |
Similar Items
-
Microbiome—Friend or Foe of Pancreatic Cancer?
by: Jaroslaw Daniluk, et al.
Published: (2021-11-01) -
The Prospect of Harnessing the Microbiome to Improve Immunotherapeutic Response in Pancreatic Cancer
by: Sherise Rogers, et al.
Published: (2023-12-01) -
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
by: Rozana Abdul Rahman, et al.
Published: (2021-07-01) -
The Interaction of Microbiome and Pancreas in Acute Pancreatitis
by: Can Zhang, et al.
Published: (2023-12-01) -
Microbiome as a biomarker and therapeutic target in pancreatic cancer
by: Ghazaleh Pourali, et al.
Published: (2024-01-01)